Zoetis Inc. ZTS | NYSE

ZTS last paid $0.53 a share on Nov 2, and lost 29.9% over 12 months with dividends counted. · 1-year total return -29.9% · Track ZTS in a free portfolio

Dividends

Company Overview:

Market Cap: $33.13B
Trailing PE: 13.5x
FWD PE *: 12.8x
Payout Ratio (TTM): 26.8%
52-Week Range: $68.77 - $132.49

* Forward PE is based on street estimates.

10 Year ZTS Performance Metrics:

Total Return (with DRIP): 73.6% (5.68% CAGR)
Total Return (no DRIP): 82.5% (6.20% CAGR)
Share Price: 58.2% (4.70% CAGR)
Yield on Cost (with DRIP): 4.65%
Total Invested: $10,000
Total Value (with DRIP): $17,365
Total Return $ (with DRIP): $7,365
Dividend Increase: 404.8% (17.59% CAGR)
Dividend Yield (FWD): 2.68% ($2.12)
ZTS 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
ZTS Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
ZTS Price CAGR:1Y: -31.74%2Y: -32.89%5Y: -18.97%10Y: 4.70%
ZTS Dividend Charts
ZTS - Dividends
ZTS Dividend CAGR:1Y: 6.00%2Y: 10.76%5Y: 16.22%10Y: 18.76%
ZTS - Dividend Payout Ratio
ZTS Dividend Payout Ratio CAGR:1Y: 20.35%2Y: 13.26%5Y: 11.44%10Y: 6.54%
ZTS - Dividend to Free Cash Flow Ratio
ZTS Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Build Custom Charts
ZTS - Chart 1
ZTS - Chart 2
ZTS - Chart 3

ZTS Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

Revenue
ZTS Revenue CAGR:1Y: -0.38%2Y: 0.06%5Y: 3.74%10Y: 6.78%
Earnings Per Share (EPS)
ZTS EPS CAGR:1Y: -11.66%2Y: -2.02%5Y: 4.42%10Y: 11.61%
Net Income
ZTS Net Income CAGR:1Y: -18.03%2Y: -6.91%5Y: 1.37%10Y: 9.48%
EBITDA
ZTS EBITDA CAGR:1Y: -16.13%2Y: -7.17%5Y: 1.49%10Y: 8.59%
Free Cash Flow
ZTS Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Free Cash Flow / Share
ZTS Free Cash Flow / Share CAGR:1Y: -4.16%2Y: 0.31%5Y: 9.11%10Y: 16.84%
Operating Income
ZTS Operating Income CAGR:1Y: -7.80%2Y: -3.15%5Y: 3.46%10Y: 8.69%
Gross Profit
ZTS Gross Profit CAGR:1Y: -1.40%2Y: 1.23%5Y: 3.81%10Y: 7.38%
Shares Outstanding
ZTS Shares Outstanding CAGR:1Y: -7.13%2Y: -4.73%5Y: -2.88%10Y: -1.89%
Share Buybacks
ZTS Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Stock-Based Comp
ZTS Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Expenses
ZTS Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Revenue vs Net Income
EPS vs FCF / Share
EPS vs PE Ratio
FCF vs FCF / Share
FCF vs Stock Based Comp
Cash & Debt
Revenue by Segment
ZTS Revenue CAGR:1Y: -0.38%2Y: 0.06%5Y: 3.74%10Y: 6.78%
Revenue by Region
ZTS Revenue CAGR:1Y: -0.38%2Y: 0.06%5Y: 3.74%10Y: 6.78%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

REVENUE: Actual + Estimates
ZTS Actual Revenue CAGR:1Y: -0.38%2Y: 0.06%5Y: 3.74%10Y: 6.78%
EPS: Actual + Estimates
ZTS Actual EPS CAGR:1Y: -11.66%2Y: -2.02%5Y: 4.42%10Y: 11.61%
NET INCOME: Actual + Estimates
ZTS Actual Net Income CAGR:1Y: -18.03%2Y: -6.91%5Y: 1.37%10Y: 9.48%
EBITDA: Actual + Estimates
ZTS Actual EBITDA CAGR:1Y: -16.13%2Y: -7.17%5Y: 1.49%10Y: 8.59%

Ratios, Profit Margins & Return on Capital:

Net Profit Margin
ZTS Net Profit Margin CAGR:1Y: -17.71%2Y: -6.97%5Y: -2.28%10Y: 2.53%
Gross Profit Margin
ZTS Gross Profit Margin CAGR:1Y: 0.85%2Y: 1.17%5Y: 0.07%10Y: 0.56%
Price to Earnings
ZTS Price to Earnings CAGR:1Y: -45.98%2Y: -38.86%5Y: -21.88%10Y: -7.74%
Price To Sales Ratio
ZTS Price To Sales Ratio CAGR:1Y: -55.48%2Y: -43.04%5Y: -23.62%10Y: -5.38%
Return on Capital Employed
ZTS Return on Capital Employed CAGR:1Y: -0.77%2Y: -2.18%5Y: 3.17%10Y: 2.16%
Return on Invested Capital
ZTS Return on Invested Capital CAGR:1Y: -6.67%2Y: -3.88%5Y: -0.06%10Y: 1.89%

Compare stocks side-by-side

ZTS Dividends Info:

Annual Dividend: $2.12
Forward Yield: 2.68%
Ex-Dividend Date: 2026-10-30
Lifetime Dividends / Share: $13.22

Projected Future Returns & Dividends for ZTS

Based on past 10-year performance, here are ZTS growth metrics:

Share price CAGR of +4.7%
Dividend CAGR of +18.92%

Using ZTS CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

ZTS (DRIP)ZTS - No DRIP
Current Price$79.11$79.11
Start Shares126.41126.41
Start Value$10,000$10,000
  
After 10 years:
Final Share Count209.32126.41
Dividends Payment$3.00$3.00
Annual Dividends$2,511$1,516
Yield on cost25.11%15.16%
Share Price$125.17$125.17
Total Dividends$8,664$6,596
Final Value$26,200$22,418

Estimated Future Value + Dividends - ZTS

NOTE: Above numbers are our estimate based on ZTS's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Zoetis Inc. (ZTS) had its IPO on 2013-02-01, and is traded on NYSE stock exchange.

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

ZTS website: https://www.zoetis.com


Loading signals…

DCF Model — ZTS

Value from:
Pay up to today
—
vs current price $79.11
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →